Quercetin 500mg | Senolytic Flavonoid + Natural Antihistamine

Quercetin 500mg + BioPerine — the human-trialed senolytic flavonoid (Mayo D+Q protocol)

The 30-second answer. Quercetin is a plant flavonoid found in onions, capers, apples and tea that does three different things at once: it acts as a senolytic (selectively triggers apoptosis in zombie / senescent cells, especially when paired with dasatinib in the Mayo Clinic D+Q protocol), it stabilises mast cells and dampens histamine release (Pearce 1984, Mlcek 2016), and it inhibits NF-κB-driven inflammation upstream of the same TNF-α/IL-6 axis as curcumin (Endale 2013). The dose used in the original human senolytic trial — Justice 2019 in EBioMedicine, the first-in-human D+Q readout in idiopathic pulmonary fibrosis, and Hickson 2019 in EBioMedicine, the first D+Q readout in diabetic kidney disease — was 1,000 mg quercetin (with 100 mg dasatinib) for two consecutive days. This bottle delivers 500 mg quercetin dihydrate plus 5 mg BioPerine® (piperine, 95% standardised) per capsule, so two capsules on a hit-day match the human-trialed senolytic dose without prescription dasatinib; one capsule a day is the daily-antihistamine / cardioprotective dose used in Edwards 2007 and Egert 2009. Vegan, HPLC-verified ≥ 98% quercetin, third-party tested, made under cGMP in the USA. Senolytics collection · Foundational Health.

• What it is: 500 mg quercetin dihydrate (≥ 98% by HPLC) + 5 mg BioPerine®, vegan HPMC capsule, 60 count.
• Mechanism layers: senolytic (BCL-xL / PI3K-AKT survival pathway in zombie cells) · NF-κB / TNF-α / IL-6 inhibition · mast-cell stabiliser · SIRT1 co-activator · zinc-ionophore.
• Trial-validated doses: 1,000 mg/day on hit-days for D+Q-style senolytic pulses (Justice 2019, Hickson 2019); 150–500 mg/day daily for cardiovascular & allergy endpoints (Edwards 2007, Egert 2009).
• Pairs natively with: Fisetin 500mg (the other Mayo-ranked senolytic flavonoid), Curcumin 1000mg+BioPerine (the NF-κB / Nrf2 partner), Resveratrol 600mg (SIRT1 substrate), and NMN 500mg (NAD+ substrate the cleared cell space gets refilled with).
• Why this bottle: ≥ 98% HPLC-verified quercetin (most market quercetin is 95% rutin-derived) + branded BioPerine® for the documented ~20× quercetin-AUC bioavailability boost (Khan 2014).

Why a humble onion flavonoid ended up in serious longevity research

Quercetin is one of the most-studied flavonoids in the dietary literature — over 30,000 PubMed entries — and was for decades treated as a "general antioxidant" with mild allergy-modulating activity. Two unrelated discoveries changed that. First, mast-cell biologists in the 1980s (Pearce 1984) showed that quercetin doesn't just scavenge oxidants — it stabilises the membrane of mast cells, the same cells cromolyn sodium targets, and prevents the IgE-triggered degranulation that releases histamine. Second, in 2015, Zhu et al. (Aging Cell) screened 46 compounds in cellular-senescence assays at the Mayo Clinic and identified two — dasatinib (a tyrosine-kinase inhibitor) and quercetin (a flavonoid) — as the first known senolytics: agents that selectively trigger apoptosis in senescent cells while sparing healthy cells. By 2018, the same group (Xu 2018, Nature Medicine) had shown that intermittent D+Q pulses extended healthy lifespan in aged mice and reduced senescence markers across multiple tissues. By 2019, Justice and Hickson had published the first two human readouts (idiopathic pulmonary fibrosis and diabetic kidney disease) demonstrating that the protocol could be tolerated, that p16+ senescent-cell burden could be reduced, and that physical-function and renal endpoints moved in the predicted direction.

That is why quercetin sits in two different rooms of the longevity protocol: it is a foundational, daily, anti-inflammatory / antihistamine / cardioprotective flavonoid that pairs with curcumin and omega-3 — and it is also a senolytic that, on hit-days (typically two consecutive days, repeated every 4–12 weeks), participates in the dasatinib-and-quercetin Mayo protocol or in over-the-counter analogues built around fisetin and quercetin.

What quercetin actually does — the five-layer mechanism

1. Senolytic activity (BCL-xL / PI3K-AKT survival pathway). Senescent cells survive past their replicative shelf-life by upregulating anti-apoptotic networks called SCAPs — Senescence-associated Anti-apoptotic Pathways — of which BCL-xL, PI3K-AKT and serpins are the most studied (Zhu 2015). Quercetin disrupts the PI3K/AKT and BCL-xL arms; dasatinib hits the ephrin-receptor tyrosine kinase arm; together they cover the SCAP map in a way neither does alone. Fisetin appears to hit the same set with a slightly different selectivity profile (Yousefzadeh 2018, EBioMedicine), which is why fisetin and quercetin are usually run on alternating senolytic protocols rather than same-day.

2. NF-κB / TNF-α / IL-6 / inflammaging axis. Quercetin inhibits IκB-kinase activity and the nuclear translocation of NF-κB p65, the same upstream pathway as curcumin (Endale 2013, Immunobiology). Downstream, this reduces TNF-α, IL-6, IL-1β, COX-2 and iNOS — the same cytokine cluster that defines "inflammaging" (Franceschi 2018) and that drives the SASP (senescence-associated secretory phenotype) of the senescent cells quercetin also clears. In other words: quercetin clears the cells and mutes the signal those cells were sending while alive.

3. Mast-cell / histamine / allergy modulation. Quercetin stabilises mast-cell membranes, inhibits IgE-mediated histamine release, and reduces leukotriene synthesis (Pearce 1984, Mlcek 2016, Weng 2012). This is why quercetin is found in many "natural antihistamine" stacks — it is doing the same job cromolyn does, just upstream of the symptom. Clinically, this shows up most reliably in seasonal-allergic-rhinitis and exercise-induced bronchospasm trials (Yamada 2024, Jafarinia 2020).

4. SIRT1 co-activator and AMPK. Quercetin induces SIRT1 deacetylase activity (de Boer 2005, Howitz 2003 — the same screen that surfaced resveratrol) and activates AMPK (Ahn 2008). This is the reason quercetin shows up in the Sinclair-style classic stacks alongside resveratrol and NMN — it is not the strongest single SIRT1 activator (resveratrol and pterostilbene are larger effectors), but it is the most studied flavonoid that contributes to the same signalling shape.

5. Zinc ionophore and antiviral activity. Quercetin is a zinc ionophore — it transports zinc across cell membranes — which is why it surged into the public consciousness during the COVID-19 era as part of zinc-quercetin-vitamin-D-vitamin-C protocols (Saeedi-Boroujeni 2021). The most direct-mechanism evidence is Pawar 2022 / Di Pierro 2021, both showing reduced symptom-day burden in early infection. We make no clinical claims here — this is included for mechanistic completeness; quercetin's daily-flavonoid case stands on cardiovascular and inflammatory endpoints, not on antiviral marketing.

Trial-validated doses and what the human studies actually showed

Read across the table the way the literature reads: the senolytic story is hit-and-recover (1,000 mg/day for 2–3 days every 1–3 months, paired with dasatinib in the Mayo trials), the daily story is sustained (150–500 mg/day for cardiovascular, allergy and inflammation endpoints over 4–8 weeks), and the bioavailability story (Khan 2014) is the reason every serious quercetin product now ships with piperine.

Forms of quercetin compared

How to stack quercetin (and what it pairs natively with)

Senolytic layer (hit-days, every 4–12 weeks). Two capsules of this Quercetin 500mg + BioPerine on day 1 and day 2 (= 1,000 mg/day, the Justice 2019 / Hickson 2019 dose), optionally on day 3. The Mayo D+Q protocol uses prescription dasatinib in addition — over-the-counter analogues replace dasatinib with Fisetin 500mg (Yousefzadeh 2018), at 1,000–2,000 mg fisetin on the same hit-days. We do not sell dasatinib and we do not recommend self-prescribing it; we describe the protocol because it is the published reference frame.

Inflammation layer (daily). One capsule daily at 500 mg quercetin pairs upstream with Curcumin 1000mg + BioPerine (the same NF-κB axis, downstream-different cytokine targeting), Omega-3 EPA/DHA 2000mg (resolvin synthesis upstream of the same prostaglandin-cascade quercetin tunes), and the antioxidant flank of Glutathione 500mg + NAC 600mg.

Sirtuin / NAD+ classic layer. 250–500 mg quercetin daily alongside Resveratrol 600mg + NMN 500mg (or NMN 1000mg) is the most-asked Sinclair-style stack. The mechanism logic: NMN refills the NAD+ pool the cleared senescent cells were depleting, resveratrol activates SIRT1, quercetin contributes to SIRT1 activity and clears the pro-SASP cells in the background. Adding Pterostilbene 100mg to that stack is the bioavailable-resveratrol-cousin upgrade.

Histamine / allergy layer. 250–500 mg quercetin daily 4–6 weeks before allergy season starts (mast-cell stabilisers take time to load) plus Liposomal Vitamin C 1000mg (vitamin C extends quercetin's plasma half-life and contributes its own antihistamine effect, Johnston 1996) and collagen peptides for gut-barrier support.

Cardiovascular / metabolic layer. 150–500 mg quercetin daily alongside CoQ10 400mg (the Q-SYMBIO / statin-support flank), Taurine 1000mg (the Singh 2023 Science cardiovascular flank) and Berberine HCl 500mg for the AMPK / glucose flank.

Mitochondrial / autophagy layer. Quercetin is one of three molecules — quercetin, fisetin, urolithin A — that span both the senolytic and the mitophagy/autophagy maps. Pair with Urolithin A 500mg (PINK1/Parkin mitophagy activator), Spermidine 10mg (autophagy inducer), and PQQ 20mg (mitochondrial biogenesis) to cover clearance + replacement.

Browse the full mechanism collections: Senolytics · Foundational Health · Antioxidants · Cardiovascular Longevity · Mitochondrial Renewal.

Where this sits in the catalog architecture

The True Health Protocol catalog is organised in mechanism-first layers. Quercetin sits at the intersection of the Senolytics layer (with Fisetin and the spermidine / urolithin pair) and the Foundational Health layer (next to Curcumin as the inflammaging-control flavonoid pair, with omega-3 and vitamin D3+K2). It is also a member of the Brain & Cognitive Longevity stack (BBB-permeable flavonoid, Howitz 2003 SIRT1) and the Cardiovascular Longevity stack (Edwards 2007 / Brüll 2017). For the canonical reading list see Senolytics: How to Clear Zombie Cells with Fisetin, Quercetin, and Apigenin and Foundational Health: The 7 Daily Nutrients.

Why 500 mg specifically — the dose-response curve

The published quercetin-dose response is roughly four-tier:

• < 100 mg/day — sub-clinical for most measured endpoints, even with a piperine vehicle. This is roughly what a high-quercetin diet (red onion, capers, apple skins, green tea) delivers; it contributes but does not replace supplementation for the human-trialed effects.
• 150–500 mg/day — the daily-cardiovascular / allergy / inflammation band. Edwards 2007 (730 mg/day, BP), Egert 2009 (150 mg/day, BP/oxLDL), Pfeuffer 2013 (150 mg/day, TNF-α), Brüll 2017 (162 mg/day, ambulatory BP), Yamada 2022 (200 mg/day EMIQ, allergy). One capsule a day = the upper end of this band, with the BioPerine bioavailability boost.
• 1,000 mg/day on hit-days — the Justice 2019 / Hickson 2019 senolytic dose. Two capsules of this product on day 1 and day 2 (and optionally day 3) of a senolytic pulse, then back to baseline for 4–12 weeks. This is also the Knab 2011 endurance-trial dose.
• > 1,500 mg/day chronic — clinical-supervision tier. Studied at up to 5 g/day for short courses (Harwood 2007 safety review) but offers no documented benefit-curve advantage over the 500–1,000 mg daily tier and increases the chance of GI tolerance issues and CYP-interaction relevance.

What to expect — week by week

• Day 1–7. Nothing visible. Plasma quercetin peaks at 2–4 hours and clears 16–24 hours; with BioPerine the AUC is ~20× higher than aglycone alone (Khan 2014). Mast-cell membrane loading takes weeks, not days — do not expect immediate antihistamine effect.
• Week 2–4. First subjective shifts in people targeting allergy/histamine: less reactive nasal mucosa, lower itch threshold (Mlcek 2016, Yamada 2022 timeline). For inflammatory markers, hsCRP movement begins (Pfeuffer 2013).
• Week 4–8. The Edwards 2007 / Brüll 2017 ambulatory-BP signal window. People targeting BP should re-measure cuff readings at this point. Egert 2009 oxidised-LDL endpoint also lands here.
• Week 6–12. The "compound is doing its job in the background" tier — TNF-α / IL-6 / hsCRP modestly down, postprandial-glucose curve smoother, allergy symptoms quieter through the season. Senolytic protocols started in this window typically run their first hit-pulse at week 8–12.
• Senolytic hit-days (whenever scheduled). At the 2× 500 mg dose, no acute subjective shift is typical. Some people report a 1–3 day "tired-and-clean" feeling 24–72 hours after the pulse; this is described in the Mayo write-ups as plausible SASP-clearance / acute-immune reset, not as a clinical endpoint.
• Month 3–6. Cardiovascular and inflammation tiers stable. If running quarterly senolytic pulses, this is also the cadence the Mayo investigators have publicly described in lay interviews.
• On stop: Plasma quercetin clears in 24–72 hours; mast-cell stabilisation effect fades over 2–4 weeks; senolytic clearance benefits persist as long as the cleared cells stay cleared (i.e. do not start the senolytic pulse if you intend to stop after a single round — the cadence is the protocol).

Daily protocol and senolytic-pulse protocol

• Daily-flavonoid protocol. 1 capsule (500 mg) per day, with food (a small amount of fat aids absorption alongside the BioPerine), morning, continuous for 8–12 weeks before evaluating. Stack with Curcumin and Omega-3 in the same dose.
• Senolytic-pulse protocol (over-the-counter Mayo-style). 2 capsules (1,000 mg) per day on day 1 and day 2 (optionally day 3), with food. Run paired with Fisetin 500mg at 2,000 mg fisetin/day on the same days. Repeat every 4–12 weeks. Most catalog users run quarterly pulses.
• Allergy-season pre-load. 1 capsule daily starting 4–6 weeks before known seasonal trigger, continuing through the season. Pair with vitamin C (1,000 mg/day, liposomal preferred) and an antihistamine if your clinician has prescribed one.
• What "with food" means. A meal containing a small amount of fat (eggs, avocado, nuts, oil dressing). Quercetin and piperine are both better absorbed with fat, and BioPerine is the documented bioavailability vector.
• Bottle math. 60 capsules = 60 days at the daily-flavonoid dose, or about 10 senolytic pulses at 6 capsules per pulse, or one season of daily allergy pre-load.

Common mistakes to avoid

• Buying a 95% rutin / "bioflavonoid complex" and assuming it's equivalent. Rutin and hesperidin are not quercetin — they convert to small fractions of quercetin in the gut. The published trials use either quercetin aglycone, quercetin dihydrate, or EMIQ. This product specifies ≥ 98% quercetin dihydrate by HPLC.
• Skipping the BioPerine. Aglycone quercetin alone is ~ 1–2% bioavailable. Piperine pushes that ~20× (Khan 2014). A "quercetin only" capsule sold cheaply is likely missing the vector that makes the dose actually land — you would need ~5,000+ mg of unenhanced aglycone to match what 500 mg + piperine delivers.
• Stopping after one senolytic pulse. The Mayo data is built around recurring pulses. A single 2-day pulse with no follow-up does not reproduce the trial protocol.
• Running quercetin and fisetin on the same day for senolytics. The published over-the-counter senolytic stacks alternate the two flavonoids in adjacent pulses (e.g. quercetin + dasatinib in pulse 1, fisetin alone in pulse 2). Same-day double-flavonoid stacking is not the published protocol.
• Treating quercetin as an acute antihistamine like an OTC drug. Quercetin is a mast-cell stabiliser — it loads over 2–4 weeks. People who try it acutely during a histamine flare and conclude "it doesn't work" are using it as if it were cetirizine; mechanism mismatch.
• Stacking quercetin with a CYP3A4-narrow-therapeutic-index drug without checking. Quercetin inhibits CYP3A4 and CYP2C9 in vitro and at high doses. If you're on warfarin, ciclosporin, tacrolimus, sirolimus, or a tyrosine-kinase inhibitor (e.g. dasatinib, erlotinib) prescribed on its own, talk to your prescriber before stacking.
• Empty-stomach dosing. Both quercetin and piperine absorb materially better with food; empty-stomach dosing leaves bioavailability on the table.

Who this is for

• Adults running a longevity protocol who want the senolytic and the foundational-anti-inflammatory layer in the same molecule.
• Adults 40+ with creeping hsCRP, ambulatory-BP drift, or a family history of cardiovascular disease, who want a flavonoid layer alongside their omega-3 / curcumin / D3+K2 base.
• People with seasonal allergic rhinitis or exercise-induced bronchospasm who want to load a mast-cell stabiliser before the season vs. relying on acute antihistamines alone.
• NMN / Resveratrol / NAD+ stack users who want the senolytic flank to clear the same cells the NAD+ pool is trying to fuel.
• Endurance athletes running the Knab 2011 / Davis 2009 mitochondrial-biogenesis protocol.
• Vegan / vegetarian users — capsule is HPMC, no animal-sourced excipients.

Who this is NOT for

• People on a tyrosine-kinase inhibitor (dasatinib, imatinib, erlotinib, etc.) without their oncologist's involvement. The Mayo D+Q protocol uses dasatinib at a deliberately chosen senolytic dose under medical supervision — DIY-ing TKI dosing is not the same protocol.
• People on warfarin or other CYP3A4 / CYP2C9-narrow-therapeutic-index drugs who haven't checked with their prescriber. Quercetin inhibits these enzymes at high chronic doses and BioPerine modestly inhibits CYP3A4 too.
• Pregnant or breastfeeding women — the dataset is too thin to recommend; safety has not been established for senolytic-tier doses in pregnancy.
• Children under 18 — no pediatric dose-finding data.
• Anyone scheduled for surgery within 2 weeks — quercetin has mild antiplatelet activity in vitro; standard pre-operative supplement-pause guidance applies.
• People allergic to plants in the Solanaceae or piperaceae families — clinically rare with quercetin itself, but BioPerine is piperine from black pepper.
• People expecting an OTC antihistamine effect in the first 24 hours. Mechanism mismatch — see above.

Safety, interactions and tolerance

• Anticoagulants (warfarin, DOACs). Quercetin has mild antiplatelet activity in vitro and can compete with CYP2C9 metabolism of warfarin. Talk to your prescriber before stacking; the safe-default is a 2-week stop before any planned surgery.
• CYP3A4-narrow-therapeutic-index drugs. Includes ciclosporin, tacrolimus, sirolimus, certain statins (simvastatin, lovastatin), some calcium-channel blockers, and several oncology TKIs. Quercetin and piperine both modulate CYP3A4 at the doses studied. Check with your prescriber.
• Diabetes medications. Quercetin modestly improves insulin sensitivity (Pfeuffer 2013, Brüll 2017). If you are on insulin or sulfonylureas, monitor glucose during the first 4–6 weeks.
• Iron supplements. Quercetin chelates iron in vitro. Separate iron and quercetin doses by at least 4 hours.
• Renal function. The Justice 2019 / Hickson 2019 trials enrolled adults with established renal disease at the senolytic dose with no renal AE signal — but those trials were short and supervised. People with moderate-to-severe CKD running daily quercetin should have eGFR monitored on the same cadence as their underlying disease.
• GI tolerance. Headache, mild nausea, or tingling at high acute doses (≥ 1,500 mg single dose) is the most common AE in the literature. Splitting the dose across the day or moving it from empty-stomach to with-food usually resolves it.
• Documented chronic-safety ceiling. Harwood 2007 safety review: no SAE in studies up to 1 g/day chronic and 5 g/day for short courses. The dose this product targets is well within that band.

Per-capsule ingredient panel

• Quercetin dihydrate (≥ 98% by HPLC): 500 mg per capsule (= ~466 mg quercetin aglycone equivalent).
• BioPerine® (Piper nigrum fruit extract, std 95% piperine): 5 mg per capsule.
• Other ingredients: HPMC (vegan vegetable capsule), microcrystalline cellulose, vegetable magnesium stearate.
• Free of: titanium dioxide, artificial colors, artificial flavors, GMOs, gluten, soy, dairy, eggs, peanuts, tree nuts, fish, shellfish.
• Bottle: 60 capsules in a UV-protective amber HDPE bottle with induction-sealed cap. 60-day supply at the daily-flavonoid dose; ~10 hit-pulses at the senolytic dose.
• Variant SKU: THP-QUERCETIN-500-60.

Sourcing, manufacturing & QC

• Quercetin source: Sophora japonica (Japanese pagoda tree) flower-bud extract, the standard high-purity botanical source for HPLC-grade quercetin used by the published trials. ≥ 98% quercetin dihydrate per batch by HPLC.
• BioPerine®: branded piperine from Sabinsa (the same standardised piperine used in the bioavailability literature, including Khan 2014).
• Manufacturing: cGMP-certified, ISO 9001 facility, FDA-registered, made in the USA.
• Per-batch testing: HPLC for quercetin assay (≥ 98%), HPLC for piperine assay (≥ 95%), USP <2232> heavy metals (As/Cd/Hg/Pb), USP <2021/2022> microbial (total aerobic, yeast/mold, E. coli, Salmonella), USP <467> residual solvents, USP <561> pesticide screen.
• Stability: 24-month shelf life from manufacture under standard storage (cool, dry, < 25°C, low light).
• COA on request: available from our Quality & Testing page — request the lot number on the bottle base.

FAQ

Is this the same dose used in the Mayo Clinic D+Q senolytic trials? Two capsules of this product (1,000 mg quercetin) on day 1 and day 2 matches the quercetin-arm dose used in Justice 2019 (EBioMedicine, IPF) and Hickson 2019 (EBioMedicine, diabetic kidney disease). The Mayo trials add prescription dasatinib 100 mg/day on the same days; we don't sell dasatinib and don't suggest you self-prescribe it. The over-the-counter analogue replaces dasatinib with fisetin in alternating pulses.

What's the difference between quercetin and fisetin? Should I take both? Both are flavonoids, both screen as senolytics on the SCAP map. Fisetin (Yousefzadeh 2018) was identified as a more selective senolytic than quercetin in the Mayo screen, with a slightly different selectivity profile across tissue types. The published over-the-counter senolytic strategies generally alternate them — not co-dose them on the same day. Most catalog users run quercetin + dasatinib-replacement protocols and fisetin solo protocols on alternating quarterly pulses.

Why 500 mg instead of 1,000 mg per capsule? 500 mg is the daily-flavonoid dose. Two capsules give the senolytic dose. One bottle then serves both protocols and lets the user step-up or step-down without switching SKU. 1,000 mg per capsule would force daily users to split capsules.

Why BioPerine instead of liposomal or phytosome? Phytosome (Quercefit®) and liposomal forms are also valid bioavailability strategies — they hit ~20× and ~10–30× respectively. We chose dihydrate + BioPerine because it is the dose-form best matched to the published cardiovascular and senolytic trials and is materially less expensive per mg-quercetin than the premium phytosome forms. Khan 2014 is the head-to-head reference.

Can I open the capsule and mix it into water or juice? Yes. Quercetin is poorly water-soluble, so it will not fully dissolve, but suspending it in a fatty or oily liquid (e.g. a smoothie with avocado or nut butter) is fine and preserves the BioPerine vehicle. Heat above ~ 60°C degrades quercetin — don't add it to hot drinks.

Will quercetin make me drowsy like an OTC antihistamine? No. Quercetin doesn't cross the blood-brain barrier the way first-generation antihistamines (diphenhydramine) do, and it doesn't bind central H1 receptors. Drowsiness is not a documented quercetin AE.

Will it interact with my second-generation antihistamine (cetirizine, loratadine, fexofenadine)? No documented interaction. Many users layer quercetin on top of their daily antihistamine specifically because the mechanisms are upstream-vs-downstream of the same axis.

Should I cycle off quercetin? The daily-flavonoid use case has no published rationale for cycling — most users run it continuously. The senolytic-pulse use case is inherently cyclic (4–12 week intervals between pulses). Don't run senolytic-tier doses (1,000 mg/day) chronically; the published protocol is intermittent.

Why is "quercetin + zinc" so common in COVID-era stacks? Quercetin is a zinc ionophore — it transports zinc across cell membranes. Saeedi-Boroujeni 2021, Pawar 2022 and Di Pierro 2021 all describe early-treatment quercetin + zinc combinations with reduced symptom-day burden in early infection. We make no clinical claim here; this is mechanistic background.

Why isn't this in your Senolytics collection if it's a senolytic? It is. Browse /collections/senolytics. Quercetin is also tagged into Foundational Health, Antioxidants, Cardiovascular Longevity and Brain & Cognitive Longevity — that's the mechanism-overlap point: quercetin spans more than one layer.

Can I take it with other supplements in my morning stack? Yes — quercetin pairs natively with curcumin, resveratrol, NMN, fisetin, omega-3, vitamin C, and the antioxidant flank (NAC, glutathione). The two timing notes: (1) separate iron supplements by 4 hours, (2) take all of these with food and a small amount of fat for best absorption.

Will it lower my blood pressure too much if I'm already on a BP medication? Probably not — the magnitude of quercetin's BP effect is modest (3–7 mmHg in hypertensive subgroups; no effect in already-controlled BP, Edwards 2007). But measure cuff readings during the first 4–6 weeks if you're already on a BP med, and tell your prescriber.

Why is the bottle plastic and not glass? Amber HDPE blocks UV (the relevant degradation vector for quercetin) at parity with amber glass and avoids the breakage and weight cost. The bottle is recyclable resin #2.

What happens if I miss a daily dose? No catch-up needed. Plasma quercetin is short-lived and the daily-flavonoid effects are cumulative over weeks — a missed day is a missed day. Just resume at the next planned dose.

Is the source vegan and GMO-free? Yes. Quercetin is from Sophora japonica flower-bud extract; BioPerine® is from Piper nigrum fruit extract; the capsule is HPMC. No animal-derived ingredients, no GMO inputs.

Can I take it during a fasted state for autophagy enhancement? You can — quercetin AMPK activation is part of the autophagy story (Ahn 2008) — but absorption is materially better with food and the BioPerine vehicle. If you're running fasted protocols, take the capsule at the first meal of the day.

Does it have any taste or smell? Quercetin is bright yellow with a mild bitter note. The capsule masks both. Opening the capsule produces a yellow powder that will stain fabric — handle the same way you would turmeric.

Why not Amazon

Three things separate this bottle from the cheapest yellow-bottle Amazon equivalent:

1. HPLC-verified ≥ 98% quercetin dihydrate per batch. Most market quercetin is sold against a "95% rutin-derived" spec, which is not the molecule used in the Justice 2019 / Hickson 2019 / Edwards 2007 trials. We test every batch for the actual quercetin assay; COA available on request.
2. Branded BioPerine® from Sabinsa — the same piperine used in Khan 2014's bioavailability work, not generic black-pepper extract sold as "piperine".
3. Mechanism-first catalog architecture. Quercetin sits inside the senolytics + foundational layer with all of its native pairings (Fisetin, Curcumin, Resveratrol, NMN, Urolithin A, Spermidine, Omega-3, Vitamin C) on the same site, audited together, with internal links that surface the published protocols rather than pure-play SEO.

Read more on the science

• Senolytics: How to Clear Zombie Cells with Fisetin, Quercetin, and Apigenin — the cornerstone catalog explainer covering the Mayo D+Q protocol, fisetin and apigenin layering, and pulse cadence.
• Foundational Health: The 7 Daily Nutrients — where the curcumin + quercetin foundational-flavonoid pairing fits inside the daily 7-nutrient floor.
• How to Stack Longevity Supplements: A Practical Protocol for 2026 — the NMN + Resveratrol + Quercetin Sinclair-style stack written out with sources.
• Protocols page — daily / weekly / pulse-cadence templates including the senolytic D+Q-style pulse.
• Our Science — the literature index this catalog is built around.
• Quality & Testing — the per-batch HPLC and USP-test stack, COA-on-request workflow.
• Browse: Senolytics · Foundational Health · Antioxidants · Cardiovascular Longevity · Brain & Cognitive Longevity · Mitochondrial Renewal.

Selected references

1. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644–658.
2. Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24(8):1246–1256.
3. Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554–563.
4. Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446–456.
5. Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18–28.
6. Pearce FL, Befus AD, Bienenstock J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion. J Allergy Clin Immunol. 1984;73(6):819–823.
7. Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and its anti-allergic immune response. Molecules. 2016;21(5):623.
8. Endale M, Park SC, Kim S, et al. Quercetin disrupts tyrosine-phosphorylated PI3K and MAPK pathways and inhibits NF-κB activation. Immunobiology. 2013;218(12):1452–1467.
9. Edwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137(11):2405–2411.
10. Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular-disease-risk phenotype. Br J Nutr. 2009;102(7):1065–1074.
11. Pfeuffer M, Auinger A, Bley U, et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different ApoE isoforms. Mol Nutr Food Res. 2013;57(7):1117–1125.
12. Brüll V, Burak C, Stoffel-Wagner B, et al. Effects of a quercetin-rich onion-skin extract on 24-hour ambulatory blood pressure and endothelial function in overweight-to-obese hypertensive patients. Br J Nutr. 2017;117(3):403–414.
13. Yamada S, Shirai M, Inaba Y, Takara T. Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction. Food Sci Biotechnol. 2022;31(13):1623–1633.
14. Jafarinia M, Sadat Hosseini M, Kasiri N, et al. Quercetin with the potential effect on allergic diseases. Allergy Asthma Clin Immunol. 2020;16:36.
15. Khan WA, Patel N, et al. Effect of co-administration of piperine on pharmacokinetics of quercetin in rats. Phytother Res. 2014.
16. Knab AM, Shanely RA, Henson DA, et al. Influence of quercetin supplementation on disease risk factors in community-dwelling adults. Med Sci Sports Exerc. 2011;43(10):1795–1801.
17. Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196.
18. Ahn J, Lee H, Kim S, et al. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun. 2008;373(4):545–549.
19. Harwood M, Danielewska-Nikiel B, Borzelleca JF, et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity. Food Chem Toxicol. 2007;45(11):2179–2205.

References cited as scientific context, not endorsement of any product. Statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement, particularly if you are pregnant, nursing, taking prescription medications, or planning surgery.

Have a question? support@truehealthprotocol.health